CDKN1B and central nervous system cancer: As controls, we utilized normal tissue from the GTEx dataset, and we further evaluated the difference in CDKN1B expression between the controls and cancer tissues from the brain lower grade glioma (LGG), ovarian serous cystadenocarcinoma (OV), thymoma (THYM), and uterine carcinosarcoma (UCS) (Fig. 1B).